Micro Invasive Glaucoma SurgeryMIGSDevices Market, Applications and Market– Industry Analysis, Size, Share, Growth and Forecast 2029 - $0



Data Bridge Market Research analyses that the Micro Invasive Glaucoma Surgery (MIGS) Devices Market is expected to reach the value of USD 5,995.46 million by 2029, at a CAGR of 33.3% during the forecast period
Industry Analysis
Micro invasive glaucoma surgery is used to treat open-angle glaucoma. Initially, to treat OAG, medication was given that reduced aqueous humor production or increased aqueous humor outflow. For mild to moderate OAG, traditionally, pharmacologic and laser treatment was performed. With the coming of micro invasive glaucoma surgery (MIGS) procedures, new options were created for those not fit for conventional surgery. An increase in the population of geriatrics and increasing government initiatives for the prevention of blindness are expected to boost the market. Rapid transition from glaucoma medication to minimally invasive glaucoma surgeries might be creating opportunities for the manufacturer of MIGS devices. However, poor reimbursement facilities might act as an obstacle for the market.
The rise in demand for micro invasive surgery is because of growing incidences of eye diseases, rising demand for micro invasive surgeries and reduced surgical trauma, propelling the need for the market in the forecast period. However, the high installation cost and shortage of skilled professionals may hamper the minimally invasive surgery market growth in the forecast period. MIGS stands for micro invasive glaucoma surgery, which helps treat glaucoma. It is a breakthrough technology in the treatment of mild to moderate glaucoma. It is an alternative to the medications given earlier and it also prevents the complications of conventional surgery. These procedures are used to lower the intra-ocular pressure of the eye to avoid damage to the optic nerve. These procedures are safer and have a very rapid recovery time compared to conventional surgery. The various MIGS devices implanted are shunts and stents to lower the IOP.
Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scope
The micro invasive glaucoma surgery (MIGS) devices market is segmented on the basis of product, target, surgery, end user and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
• MIGS stents
• MIGS shunts
• Others
• Trabecular meshwork
• Suprachoroidal space
• Subconjunctival filtration
• Reducing aqueous production
Surgery Type
• Glaucoma in conjunction with cataract
• Stand-alone glaucoma
End User
• Hospital outpatient departments (HOPD)
• Ophthalmology clinics
• Ambulatory surgery centers (ASCS)
• Others
Distribution Channel
• Direct tender
• Retail sales
Get the sample copy of the report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-micro-invasive-glaucoma-surgery-migs-devices-market
Micro Invasive Glaucoma Surgery (MIGS) Devices Market Regional Analysis/Insights
The micro invasive glaucoma surgery (MIGS) devices market is analysed and market size insights and trends are provided by country, product, target, surgery, end user and distribution channel as referenced above.
The countries covered in the micro invasive glaucoma surgery (MIGS) devices market report are
• U.S.
• Canada and Mexico in North America
• U.K.
• Germany
• France
• Spain
• Italy
• Netherlands
• Switzerland
• Russia
• Belgium
• Turkey and the rest of Europe in Europe
• China
• South Korea
• Japan
• India
• Australia
• Singapore
• Malaysia
• Indonesia
• Thailand
• Philippines and the rest of Asia-Pacific in the Asia-Pacific (APAC)
• South Africa
• Saudi Arabia
• U.A.E.
• Israel
• Egypt and the rest of the Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
• Brazil
• Argentina and rest of South America as part of South America.
Competitive Landscape and Micro Invasive Glaucoma Surgery (MIGS) Devices Market Share Analysis
The micro invasive glaucoma surgery (MIGS) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus on the micro invasive glaucoma surgery (MIGS) devices market.
Some of the major players operating in the micro invasive glaucoma surgery (MIGS) devices market are
• AbbVie,
• BVI,
• Ellex,
• Glaukos Corporation,
• Johnson and Johnson,
• Alcon,
• Microsurgical technology,
• New World Medical,
• Santen Pharmaceutical,
• Nova Eye Medical Limited,
• Belkin Vision and Sight Scientific
• Among others.
Get Full Access of reports @ https://www.databridgemarketresearch.com/reports/global-micro-invasive-glaucoma-surgery-migs-devices-market
 Chapter One: Introduction
 Chapter Two: Market Segmentation
 Chapter Three: Market Overview
 Chapter Four: Executive Summary
 Chapter Five: Premium Insights
 Chapter Six: Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market by Product & Procedure type
Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-micro-invasive-glaucoma-surgery-migs-devices-market
Browse Related Reports @
About Us:-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]